Johnson & Johnson posts higher sales, big 4Q profit jump
Higher prescription drug sales and lower legal costs drove Johnson & Johnson's fourth-quarter profit 32% higher.
Become a Subscriber!
You have read all of your free articles this month. Select a plan below to start your subscription today.
Already a subscriber? Login
